Page last updated: 2024-09-03

4-((2-chloroethyl)(2-mesyloxyethyl)amino)benzoylglutamic acid and Thrombopenia

4-((2-chloroethyl)(2-mesyloxyethyl)amino)benzoylglutamic acid has been researched along with Thrombopenia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bagshawe, KD; Begent, RH; Cushen, N; Green, AJ; Martin, J; Napier, MP; O'Malley, D; Sharma, SK; Springer, CJ; Stribbling, SM1

Trials

1 trial(s) available for 4-((2-chloroethyl)(2-mesyloxyethyl)amino)benzoylglutamic acid and Thrombopenia

ArticleYear
Antibody-directed enzyme prodrug therapy: efficacy and mechanism of action in colorectal carcinoma.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:3

    Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Agents; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; gamma-Glutamyl Hydrolase; Glutamates; Humans; Male; Middle Aged; Neutropenia; Nitrogen Mustard Compounds; Prodrugs; Survival Analysis; Thrombocytopenia; Treatment Outcome

2000